Key Documents

View All Documentation

U0100000

Uracil arabinoside

Name: Uracil arabinoside
Brand: SIAL

European Pharmacopoeia (EP) Reference Standard

Synonym(s):

Uracil 1-β-D-arabinofuranoside, 1-β-D-Arabinofuranosyluracil

Select a Size

Change View

About This Item

Empirical Formula (Hill Notation):

C₉H₁₂N₂O₆

CAS Number:

3083-77-0

Molecular Weight:

244.20

UNSPSC Code:

41116107

NACRES:

NA.24

PubChem Substance ID:

329827589

MDL number:

MFCD00065998

Beilstein/REAXYS Number:

28749

Technical Service

Need help? Our team of experienced scientists is here for you.

Let Us Assist

Properties

grade

pharmaceutical primary standard

API family

uracil arabinoside

manufacturer/tradename

EDQM

application(s)

pharmaceutical (small molecule)

format

neat

storage temp.

2-8°C

SMILES string

OC[C@H]1O[C@H]([C@@H](O)[C@@H]1O)N2C=CC(=O)NC2=O

InChI

1S/C9H12N2O6/c12-3-4-6(14)7(15)8(17-4)11-2-1-5(13)10-9(11)16/h1-2,4,6-8,12,14-15H,3H2,(H,10,13,16)/t4-,6-,7+,8-/m1/s1

InChI key

DRTQHJPVMGBUCF-CCXZUQQUSA-N

Description

General description

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

Application

Uracil arabinoside EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.

Packaging

The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

Other Notes

Sales restrictions may apply.

Still not finding the right product?

Explore all of our products under Uracil arabinoside

Storage Class

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documents section.

If you need assistance, please contact Customer Support

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Toxicology. 'Humanized' mouse detects deadly drug side effects.

Jon Cohen

Science (New York, N.Y.), 344(6181), 244-245 (2014-04-20)

Patients with chronic hepatitis B treated with oral antiviral therapy retain a higher risk for HCC compared with patients with inactive stage disease.

Ju-Yeon Cho et al.

Gut, 63(12), 1943-1950 (2014-03-13)

It is generally stated that oral antiviral therapy in patients with chronic hepatitis B (CHB) decreases the risk of developing hepatocellular carcinoma (HCC). Although oral nucleos(t)ide analogues (NUCs) may induce a state similar to inactive stage CHB, the long-term risk

Global Trade Item Number

SKU	GTIN
U0100000	04061833801512